Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States: 1994-2003.
Teshale
Eyasu H
EH
Division of HIV/AIDS Prevention, National Center for HIV, Sexually Transmitted Disease, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. eht4@cdc.gov
Hanson
Debra L
DL
Wolfe
Mitchell I
MI
Brooks
John T
JT
Kaplan
Jonathan E
JE
Bort
Zuleika
Z
Sullivan
Patrick S
PS
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D000293:Adolescent; D000328:Adult; D015897:Comorbidity; D005260:Female; D005657:Fungal Vaccines / Q000008:administration & dosage*; D019538:Health Care Surveys; D006801:Humans; D015994:Incidence; D008297:Male; D015999:Multivariate Analysis; D045363:Pneumocystis carinii / Q000302:isolation & purification*; D011020:Pneumonia, Pneumocystis / Q000453:epidemiology / Q000517:prevention & control*; D011322:Primary Prevention / Q000592:standards / Q000639:trends; D011336:Probability; D011787:Quality of Health Care; D018570:Risk Assessment; D014481:United States / Q000453:epidemiology; D014611:Vaccination / Q000592:standards / Q000639:trends
D005657:Fungal Vaccines